[1]
2018. Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S86. DOI:https://doi.org/10.25251/skin.2.supp.87.